Por: RTTNews Health April 27, 2023
AstraZeneca PLC (,) reported that its first quarter profit before tax increased to $2.26 billion from $553 million, last year. Earnings per share was $1.16 compared to $0.25. Core operating profit was $3.95 billion, an increase of 4% at CER. Core operating margin was 36%, up one percentage point. Core EPS increased 6% to $1.92. First quarter total revenue was $10.88 billion, down 4% from last year. Total revenue was stable at CER. Total revenue... + full article
The Boston Globe USA Business June 14, 2023
ENERGYAstraZeneca signs deal with Waltham-based firm for renewable natural gasVanguard Renewables has signed a contract with drug giant AstraZeneca to deliver renewable natural gas to all of AstraZeneca’s 12 sites in the United States. Waltham-based Vanguard is developing... + más
High school scores and top performers from Friday, March 24 | Orlando Sentinel
High school scores and top performers from Thursday, March 9 | Orlando Sentinel
CBS News USA Politics April 28, 2023
A replacement for a key COVID-19 antibody drug that has been used to protect immunocompromised Americans could be available within months, executives for drugmaker AstraZeneca said Thursday, after promising early results suggested it may work against all known variants of... + más
FDA withdraws emergency use authorization of COVID drug because it is unlikely to be effective against new variants | ABC News
FDA pulls authorization for AstraZeneca’s Covid antibody drug Evusheld | NBC News
CNBC USA Business February 09, 2023
AstraZeneca has blockbuster projects in development that are set to make billions of dollars, according to its CFO.BSIP / Contributor / Getty ImagesDemand for Covid-19 vaccines has dropped as the pandemic enters its fourth year, but says it has blockbuster projects in... + más
Is the last 'Blockbuster' still open? The truth about Netflix show location | Newsweek
Last Blockbuster store, located in Oregon, to host contest winner for exclusive movie and game night | Fox Business
ABC News USA Health January 27, 2023
The U.S. Food and Drug Administration said Thursday it is withdrawing its emergency use authorization of a as a prevention tool because it is unlikely to be effective against variants that are currently circulating.Evusheld, which is made by British-Swedish pharmaceutical and... + más
FDA halts authorization of Evusheld, citing medication insufficient against viral COVID-19 variants | ABC7
FDA pauses US authorization for Eli Lilly's COVID treatment drug | Fox Business
NBC News USA Nation January 27, 2023
The Food and Drug Administration has withdrawn emergency use authorization for AstraZeneca’s Covid-19 antibody cocktail Evusheld as the treatment is not expected to neutralize the currently dominant XBB.1.5 subvariant of omicron. The FDA had limited Evusheld’s use... + más
The New York Times USA Sports November 26, 2022
AL KHOR, Qatar — The chant came from deep in one corner of the stadium, ringing out loud and clear for a few moments before fading back into the general cacophony of the night.“It’s called soc-cer!” the United States fans bellowed at their England counterparts. “It’s... + más
Football or soccer? It's complicated ... | CNN
'The greatest sporting upset of all time': When the US beat the 'giants' of England at the 1950 World Cup | CNN
Time USA Health October 31, 2022
The U.S. led the world in quickly developing COVID-19 vaccines—one of the few bright spots in the country’s otherwise criticized response. But while injectable vaccines are effective in protecting people from getting sick with COVID-19, they are less able to block infection.... + más
Without a nasal vaccine, the U.S. edge in fighting Covid is on the line | Politico
Nasal COVID vaccine blows clinical trial, flinging researchers back to the lab | Ars Technica
About iurex | Privacy Policy | Disclaimer |